A Long-Term Follow-up Study for Subjects Previously Treated with A Century Therapeutics Cellular Therapy Product
CNTY-LTFU-01
Phase 1 other active
Quick answer
A Long-Term Follow-up Study for Subjects Previously Treated with A Century Therapeutics Cellular Therapy Product for Hematological or solid tumor malignancies or autoimmune diseases is a Phase 1 program (other) at Century Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Century Therapeutics
- Indication
- Hematological or solid tumor malignancies or autoimmune diseases
- Phase
- Phase 1
- Modality
- other
- Status
- active